Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 19 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 hours agoBut Moderna turned in per-share losses of $12.33, reversing from a year-earlier gain of $20.12 a...
CDC is considering changing recommended age for meningitis vaccine; not all agree
ABC Action News Tampa Bay· 4 days ago“Meningococcal disease is a bacterial infection that is, while rare, potentially fatal,” said Dr....
Mum's guilt after 'infecting baby with whooping cough' that caused brain damage
The US Sun· 9 hours agoA MUM has admitted to feeling 'immense guilt' every day after passing whooping cough onto her...
3 Meme Stocks That Are Likely to Crater in 2024
InvestorPlace· 8 hours agoMeme stocks have the potential to completely change the portfolio health even with a limited exposure of 5% to 10%. At the same time, there are meme...
Cholera is making a comeback — and the world doesn’t have enough vaccines
Vox· 2 weeks agoThe global stockpile of the oral cholera vaccine — a supply whose needs are difficult to predict and...
Is This a Setback for Moderna?
The Motley Fool via AOL· 8 hours agoBut if the FDA were to fall further behind and Moderna were to miss out on the fall vaccination opportunity...'s also important to remember that Moderna...
Earnings call: Bavarian Nordic sees demand rise for travel vaccines By Investing.com
Investing.com· 3 days agoIn the first quarter, Bavarian Nordic experienced a surge in demand for its travel health portfolio,...
...Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of...
Loudoun Times-Mirror· 2 weeks agoMicron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and < ...
GSK raises profit outlook on strong vaccine, HIV drug sales By Reuters
Investing.com· 2 weeks agoCEO Emma Walmsley's strategy has focussed on vaccines, cancer and infectious diseases and a shift in...
